Biomarkers in NSCLC- Infographic
Discovery of tumor specific oncogenic biomarkers and molecular tests to identify them are providing treatment options to physicians based on the individual patient’s tumor characteristics. Precision medicines based on these biomarkers are becoming a reality for many diseases including lung cancer.
This infographic showcases such interventions which are being developed in NSCLC based on the individual biomarker profile of a patient.
Potential therapies based on clinically relevant biomarkers in non-small cell lung cancer (NSCLC)